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INTRODUCTION
Abnormal uterine bleeding (AUB) consists of all
menstrual abnormalities, both in the amount and
duration. Clinical manifestations may include bleed-
ing, prolongation of menstrual cycle or irregular
cycle.1,2 AUB is a disorder most commonly encoun-
tered in daily practice in gynecology and a part of
the largest problems in women. It is often present
with varied clinical picture and is considered a com-
plicated problem.3 Its incidence amounts to 19.1%
of all clinical visits for gynecological cases. In addi-
tion, it was reported that approximately 25% of all
gynecologic surgery is related to abnormal uterine
bleeding.4
AUB affects women by causing a decrease in pro-
ductivity. This is due to a disturbance in the mens-
trual cycle and the amount of blood lost that can
lead to anemia if not treated in a comprehensive
manner. Given the high number of women of re-
productive age in the population in Indonesia, and
Abstract
Objective: To determine the endometrial histology in abnormal
uterine bleeding (AUB) patients with risk factors.
Method: This study involved 30 patients with complaints of AUB,
aged over 35 years with associated risk factors of parity, obesity and
fasting blood glucose in the outpatient clinic at Prof. Dr. R. D. Kan-
dou General Hospital Manado, from July 2013 until October 2013.
Patients who agreed to be involved in this study, underwent dilatation
and curettage (D&C) to assess the endometrial histology that was
grouped as the hyperplasia and non-hyperplasia groups.
Result: From the results of the study, 7 patients were in the 35-40
years age group (23.3%) and in the 41-50 years age group were 23 pa-
tients (76.7%). Based on parity, 11 patients (36.7%) were nulliparous
and 19 patients (63.3%) were multiparous. Based on the BMI, 16 pa-
tients (53.5%) were obese and 14 patients (46.7%) were non-obese.
And based on the results of fasting blood sugar, similar results was
obtained in normal and abnormal fasting blood glucose with the re-
sults of 15 patients in each groups (50%). And from all of patients
who underwent D&C, endometrial hyperplasia was shown in 21 pa-
tients (70%) and non-hyperplasia endometrium in 9 patients (30%).
From the results of Fischer exact test, a significantly high association
was obtained between BMI and fasting blood glucose with the occur-
rence of endometrial hyperplasia.
Conclusion: There is a significant relationship between BMI and high
fasting blood glucose with endometrial hyperplasia.
[Indones J Obstet Gynecol 2015; 3: 146-150]
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Abstrak
Tujuan: Untuk mengetahui gambaran histologi endometrium pada pen-
derita PUA dengan faktor risiko.
Metode: Penelitian ini melibatkan 30 pasien dengan keluhan PUA
yang berusia di atas 35 tahun dan dihubungkan dengan faktor risiko
paritas, obesitas dan gula darah puasa di poliklinik RSUP Prof. Dr.
R. D. Kandou Manado, sejak Juli 2013 sampai Oktober 2013. Pasien
yang telah setuju untuk terlibat dalam penelitian ini dilakukan D&C
untuk mengetahui gambaran endometrium yang dikelompokkan da-
lam kelompok hiperplasia dan non-hiperplasia.
Hasil: Dari hasil penelitian terhadap 30 pasien yang datang dengan
keluhan PUA dan setuju dilakukan D&C didapatkan hasil pada kelompok
usia 35-40 tahun sebanyak 7 pasien (23,3%) dan kelompok usia 41-50 ta-
hun sebanyak 23 pasien (76,7%). Berdasarkan paritas didapat 11 pasien
(36,7%) nullipara dan 19 pasien (63,3%) multipara. Berdasarkan BMI
didapatkan 16 pasien (53,5%) dengan obesitas dan pasien non-obese se-
banyak 14 pasien (46,7%). Dan berdasarkan hasil gula darah puasa dida-
patkan hasil yang sama pada gula darah puasa normal dan gula darah puasa
yang tidak normal dengan hasil masing-masing 15 pasien (50%). Dari se-
mua pasien yang dilakukan D&C didapatkan hasil hiperplasia endome-
trium sebanyak 21 pasien (70%) dan non-hiperplasia endometrium seba-
nyak 9 pasien (30%). Dari hasil uji statistik Fischer exact test didapatkan
hubungan yang bermakna antara BMI dan gula darah puasa yang tinggi
dengan terjadinya hiperplasia endometrium.
Kesimpulan: Terdapat hubungan bermakna antara BMI dan gula darah
puasa yang tinggi dengan hiperplasia endometrium.
[Maj Obstet Ginekol Indones 2015; 3: 146-150]
Kata kunci: gula darah puasa, hiperplasia endometrium, IMT, paritas,
PUA, usia
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the higher life expectancy in premenopausal and
menopausal patients compared to the past, the nega-
tive impact of AUB will unconsciously decrease the
productivity of Indonesia in the medium and long
term.
Abnormal uterine bleeding can occur at any age
between menarche and menopause, more common-
ly in the early years after menarche and at the end
of the ovarian cycle. At perimenarche age, the most
likely cause is a disorder of blood clotting factors
and psychological causes.4 At puberty and after me-
narche, abnormal uterine bleeding is caused by im-
paired or delayed maturation in the hypothalamus,
which interrupts the gonadotropin hormone releas-
ing factor and gonadotropin hormone. In particular,
in adult women of reproductive age and in pre-
menopausal period with abnormal uterine bleeding,
curettage is necessary to determine the presence or
absence of endometrial abnormalities. Endometrial
curettage is also a procedure that is effective in con-
firming any endometrial abnormalities.5
Schröder, in 1915, conducted a histopathological
study on the uterus and ovaries at the same time,
drawing the conclusion that a bleeding disorder
called hemorrhagic metropathy happens due to the
persistence of follicles which is not broken, so there
is no ovulation and corpus luteum formation. As a
result, endometrial hyperplasia occurred due to ex-
cessive and continuous estrogen stimulation. This
explanation is still acceptable for most cases of
AUB.6
Endometrial hyperplasia is a condition in which
the endometrium grows excessively. These abnor-
malities are benign, but in some cases can progress
toward uterine malignancies. The histologic features
of endometrial hyperplasia are glandular prolifera-
tion with changes in the shape and size, as well as
an increase of glandular and stromal ratio.7,8 In ge-
neral, endometrial hyperplasia is divided into 4
types, namely simple, complex, simple with atypia
and complex endometrial hyperplasia with atypia.
Simple and complex endometrial hyperplasia is dis-
tinguished by changes in the structure of the com-
plexity and amount of stroma between the glands,
regardless of the existence of atypic cells.8
The diagnosis of atypical hyperplasia is based on
the description of a specific core, the core is large,
round, have irregular nuclear membrane, and is of-
ten accompanied by stratification of 2-4 cells with
loss of polarity associated with the basement mem-
brane. Chromatin is dispersed and clustered along
the nuclear membrane to form a vesicular picture.
These vesicular nuclei are characteristic of atypic hy-
perplasia.9 Aiza Saadia et al found that 40 percent
of endometrial hyperplasia was identified from the
results of endometrial curettage and that endo-
metrial curettage had 100 percent specificity in the
diagnosis of endometrial abnormalities and endo-
metrial cancer.5
Treatment with progesterone is an ideal treat-
ment for simple or complex endometrial hyperplasia
without atypia. Considering that both simple and
complex atypical endometrial hyperplasia has the
potential towards malignancy, the best treatment is
hysterectomy.9
Some women are at higher risk of endometrial
hyperplasia and endometrial cancer. Furthermore,
endometrial hyperplasia is a precursor of endo-
metrial cancer.10,11 Patients with endometrial hyper-
plasia usually present with abnormal bleeding, which
can include menorrhagia, metrorrhagia, menome-
trorrhagia, or postmenopausal bleeding. We must be
cautious of endometrial cancer for people aged over
35 years who present with bleeding.10
Endometrial hyperplasia often occurs in some
women who are at high risk.11,12 This includes
patients aged over 35 years, preceded by missed
period or amenorrhea, obesity (causing peripheral
conversion of androgens to estrogen in fat tissue),
patients with diabetes mellitus, nulliparous, long-
term users of estrogen without progestin adminis-
tration in postmenopausal cases, PCOS, and pa-
tients with ovarian tumors of granulose theca cell
types.
Endometrial cancer is still not familiar for the
public. The type of cancer that is popular among
women is breast cancer, cervical cancer, or uterine
cancer. Although the likelihood of mortality or
death rate of patients is smaller than that of other
cancers, endometrial cancer still carries its own
risks.13
When viewed in descriptive epidemiology, in In-
donesia there is no data on the number of cases of
endometrial cancer. RSCM Jakarta found 72 new
cases during the year 1993-2004 and found that
63.9% of patients were aged >50 years. The in-
cidence of endometrial cancer is increasing in Indo-
nesia, because the majority of people are living
longer and the presence of more accurate reporting.
Approximately 32,000 cases are estimated to occur
each year resulting in 5900 deaths. One third of
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women with postmenopausal bleeding have uterine
cancer. The average age of patients with endometrial
cancer was 61, and most patients are at least 55 years
old.13
Since the cervical cancer death rate has decreased
by more than 50% due to the progress in screening
and early detection, the incidence of endometrial
cancer is found to be second in gynecologic malig-
nancies. The number of people diagnosed with
endometrial cancer each year continues to rise.14
In this study, patients with AUB accompanied
by risk factors of over 35 years of age, obesity, high
blood sugar and nulliparity, had their endometrial
histology examined to determine the possibility of
endometrial hyperplasia occurrence, which is a pre-
cursor of endometrial cancer. Endometrial sampling
can be performed by dilatation and curettage, hys-
teroscopy, and endometrial aspiration. Dilatation
and curettage is still regarded as the most effective
method because other than as a diagnostic tool, it
can also simultaneously control bleeding in patients
with AUB without abnormalities in the uterus or
systemic abnormalities.15,16 Histologic examination
in this study is conducted by dilatation and curet-
tage for diagnosis as well as therapy in patients with
abnormal uterine bleeding.17,18
In Manado, there are no studies showing the in-
cidence of AUB that leads to endometrial hyper-
plasia and endometrial hyperplasia predisposing fac-
tors. Therefore, we aim to examine endometrial his-
tology in patients with AUB aged >35 years old
(reproductive age, premenopausal and menopause),
with suspected risk factors affecting the possibility
of malignancy.
METHODS
This research is a cross sectional study with analytic
approach. The population is AUB patients aged over
35 years who came for treatment at the outpatient
clinic of Prof. Dr. R. D. Kandou General Hospital,
Manado during the period of July 2013 to October
2013. This is also associated with risk factors of age,
parity, obesity and fasting blood glucose. Patients
who have agreed to participate in this study un-
derwent D&C to determine the histologic picture
of endometrium, and are grouped into the hyper-
plasia and non-hyperplasia group. The data obtained
is analyzed statistically by performing Fischer’s
exact test to assess the significance of a relationship
of the specified risk factors in influencing AUB.
RESULTS
On the characteristics of the patient sample by age,
we obtained that in our patients AUB most com-
monly occurred in the 41-50 years age group, con-
sisting of 23 samples (76.7%), and in the 35-40 years
age group consisted of 7 samples (23.3%). Based on
parity, we obtained that the multiparous group con-
sisted of a total of 19 samples (63.3%) and the nul-
liparous group consisted of 11 samples (36.7%).
Based on the BMI classification, AUB patients were
more likely to be obese with 16 samples (53.3%) in
the obese group, while in the non-obese group con-
sisted of 14 samples (46.7%). From the fasting
blood glucose, either group of normal and abnormal
glucose profile each obtained 15 samples (50%). Af-
ter performing D&C on the 30 samples, it was
found that 21 samples (70%) had hyperplasia, and
9 samples (30%) had non-hyperplasia.
Table 1. Sample Characteristics Based on Age
Age




In regards to age, we obtained that among pa-
tients who were 35-40 years of age, 5 were found
to have hyperplasia and 2 were observed as non-
hyperplasia. Among patients over 40 years old, the
result was 16 with hyperplasia and non-hyperplasia
was as many as 7. Analysis using Fischer exact test
found that p=1.00, indicating that there is no sig-
nificant relationship between age and the status of
endometrial hyperplasia.
Table 2. Sample Characteristics Based on Parity
Parity




In regards to parity, we found that in the nulli-
parous group, 8 patients had endometrial hyper-
plasia and 3 did not have hyperplasia. In the multi-
parous group, as many as 14 showed hyperplasia and
5 did not have hyperplasia. The p-value based on
Fischer exact test was 1.00, implicating that there is
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no relationship between parity with endometrial
hyperplasia as determined by D & C.
Table 3. Sample Characteristics Based on BMI
BMI
D & C Result
Hyperplasia Non-Hyperplasia
> 25 16 0
< 25 5 9
In our sample, all the patients in the obese group
had endometrial hyperplasia. Meanwhile, among
patients whose BMI was lower than 25 kg/m2, five
had hyperplasia and nine did not have hyperplasia.
The results of Fischer exact test showed that there
is a significant association between BMI status
endometrial hyperplasia (p=0.00).
Table 4. Sample Characteristics based on Fasting Blood 
     Glucose
Fasting Blood
Glucose




From the patient characteristics based on fasting
blood glucose, we found that in the group with nor-
mal fasting blood glucose, eight had endometrial hy-
perplasia and seven did not. However, in patients
with abnormal fasting blood glucose, as much as 14
patients had hyperplasia and only one was found
without hyperplasia. The result of Fischer exact test
indicates that there is a significant relationship be-
tween fasting blood glucose and endometrial hyper-
plasia (p=0.035).
DISCUSSION
Based on our results, most of our patients were aged
41-50 years old (76.7%). Two-thirds of women who
were treated for AUB in our hospital were aged over
40. In the study by Dinic et al in Serbia, it was con-
cluded that the incidence of AUB increases with the
age of patients. In their study, 2.13% was <30 years
old, as much as 35.8% were aged 30-45 years old,
and the majority was older than 45 years old
(61.9%). The data characteristic above is similar to
our study, in which patients with AUB mostly be-
longed to the 41-50 years age group.
After further analysis, we found that of the 23
samples aged 41-50 year old, 16 samples (69.5%)
had endometrial hyperplasia and 7 samples did not
have hyperplasia. Subhankar et al in India obtained
as much as 34.5% endometrial hyperplasia with a
sample of 252 patients and the highest incidence
being in the perimenopausal age group (aged 46-50
years).19
In this study we found no association between
age and status of endometrial hyperplasia, although
there seems to be clinically significant endometrial
hyperplasia occurring in above 40 years of age, with
a total 16 of 23 samples. Statistically, this could be
caused by a random error factor. In general, of all
the subjects aged over 35 years old in this study,
histology of hyperplasia was obtained in 21 patients.
Based on the characteristics of parity, we ob-
tained that the patients with AUB in this study is
mostly comprised of multiparous women (63.3%)
and 36.7% consist of nulliparous women. These re-
sults is same with the results of Subhankar et al,
that found 88.5% of 252 patients with AUB were
multiparous.19
Out of the 11 patients who were nulliparous,
72.7% had a picture of endometrial hyperplasia,
while out of the 19 multiparous patients as many as
14 patients (73.7%) had a picture of hyperplasia.
Clinically, the incidence of endometrial hyperplasia
is similar between nullipara and multipara, but sta-
tistically there was no significant association be-
tween parity and the status of endometrial hyper-
plasia. Theoretically, hyperplasia occurs more fre-
quently in the nulliparous group, where there is an
increase in cumulative exposure to estrogen because
of the higher total number of menstrual cycles
throughout life. Our results could be explained by
the possibility of random error, and further re-
search of AUB on nullipara population should be
carried out.
Based on the characteristics of BMI we disco-
vered that AUB incidence was slightly higher in the
obese group (53.3%), compared to the non-obese
group (46.7%). Parazzini et al in Italy observed that
60.4% of endometrial hyperplasia patients had BMI
>25. Of the 16 samples with obesity, all of them
had the histologic picture of endometrial hyper-
plasia, so that clinical data shows the influence of
obesity on endometrial hyperplasia. Whereas the
sample with a lower BMI, showed that the majority
did not have endometrial hyperplasia. Statistical
tests showed that there was a significant relationship
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between BMI with endometrial hyperplasia. So both
clinically and statistically, our result was in accor-
dance with the theory in which hyperplasia is a di-
sease that is estrogen-dependent, with endogenous
and exogenous estrogen stimulating endometrial
proliferation excessively.12
Based on the fasting blood glucose, the normal
and abnormal groups both had equal samples. In
statistical tests, we obtained that in the group with
abnormal fasting blood glucose the results is not
normal, with 14 samples showing histologic picture
of endometrial hyperplasia. Meanwhile, the occur-
rence of endometrial hyperplasia is approximately
equal in populations with normal blood sugar. Clini-
cally, we obtained that 93.3% of samples with high
fasting blood glucose had symptoms of AUB
showing histology of endometrial hyperplasia. Sta-
tistically, we found a significant relationship be-
tween fasting blood glucose and endometrial hyper-
plasia. This is consistent with the theory stating that
women with diabetes have a two-fold risk of de-
veloping endometrial hyperplasia.20 Lindemann et al
(2010) mentioned that the risk of developing en-
dometrial cancer is three times higher in diabetes
patients.11
CONCLUSION
There is a significant relationship between BMI and
high fasting blood glucose with endometrial hyper-
plasia, but this significant relationship was not iden-
tified between age and parity towards endometrial
hyperplasia. This research is a beginning to reveal
the endometrial histology in AUB, in relation with
numerous risk factors. In this study, we hypothe-
sized that examination of BMI and fasting blood
glucose can be used to predict the likelihood of ma-
lignancy in patients with AUB. However, further
research is needed with a larger sample size and
evaluating other risk factors to improve the accuracy
of the study.
REFERENCES
1. Bradley LD, Malgorzata E, Wikiel S. Investigation of ab-
normal uterine bleeding in peri and postmenopausal
women. Menopause Mangement 2008: 13-21.
2. Farquhar CM, Lethaby A, Sowter M, et al. An evaluation
of risk factors for endometrial hyperplasia in premeno-
pausal women with abnormal menstrual bleeding. J Obs-
tet Gynecol 1999; 181: 525-9.
3. Baziad A, Hestiantoro A, Wiweko B. Panduan Tata Lak-
sana PUA. Himpunan Endokrinologi Reproduksi dan
Fertilitas Indonesia; 2011: 1-31.
4. Albers JR, Hull SK, Wesley RM. Abnormal uterine
bleeding. Am Fam Physician 2004; 69(8): 1915-26.
5. Saadia A, Mubarik A, Zubair A, et al. Diagnostic accuracy
of endometrial curettage in endometrial pathology. Ori-
ginal article in J Ayub Med Coll Abbottabad 2011: 129-
31.
6. Serdar BE. The physiology and pathology of the female
reproductive axis. William Textbook of Endocrinology.
10th Ed. USA: Elsevier; 2003: 587-99.
7. Karen JC, Stephanie A, Ziporyn TD. Endometrial cancer.
In: The New Harvard Guide to Women’s Health. USA:
Harvard University Press; 2004: 215-23.
8. Chudnoff S. Endometrial Hyperplasia. [Online]. Available
from: URL:http://www.medscape.com/womenshealth
9. Giuntolli RL, Zacur HA. Classication and Diagnosis of
Endometrial Hyperplasia. [Online]. Available from:
URL: http://www.uptodate.com/contents/classification-
and-diagnosis-of-endometrial-hyperplasia. Accessed on 2
May 2013.
10. Wolfman W. Asymptomatic endometrial thickening in
SOGC Clinical Practice Guideline. JOGC 2014; 249:
990-9.
11. Lindemann K, Vatten LJ, Ellstrøm-Engh M, et al. Body
mass, diabetes and smoking and endometrial cancer risk:
a follow up study. Bri J Cancer 2008; 98(9): 1582-5.
12. Kaaks R, Lukanova A, Kurzer MS. Obesity, endogenous
hormones, and endometrial cancer risk. A synthetic re-
view. Cancer Epidemiol Biomarkers Prev 2002; 11: 1531.
13. Imam Rasjidi. Epidemiologi Kanker pada Wanita. Jakarta:
Sagung Seto; 2010: 18-22
14. Purwanti D. Kanker Endometrium. Thesis. Palembang:
FKM Unsri. Available from: URL:ptmfkmunsri.blog-
spot.com/2013/03/kanker-endometrium.html. Accessed
on 5 May 2013.
15. Sarwar A, Haque AU. Types and frequencies of patho-
logies in endometrial curettings of abnormal uterine
bleeding. Int J Pathol 2005; 3(2): 65-70.
16. McCluggage WG. My approach to the interpretation of
endometrial biopsies and curreting. J Clin Pathol 2006;
59: 801-12.
17. Hunter DC, McClure N. Abnormal uterine bleeding: an
evaluation endometrial biopsy, vaginal ultrasound and
outpatient hysteroscopy. Ulster Med J 2001; 70(1): 25-
30.
18. Machado LS. Correlation of endometrial thickness, cycle
day and histopathology in women with abnormal uterine
bleeding. Saudi Med J 2005; 26(2): 260-3.
19. Subhankar D, Barunoday C, Rejaul K, et al. Abnormal
uterine bleeding in peri-menopausal age: diagnostic op-
tions and accuracy. J Obstet Gynecol India 2011; 61(2):
426-30.
20. Parazzini F, Vecchia C, Negri E. Diabetes and endo-
metrial cancer: an Italian case control study. Int J Cancer
1999; 81(4): 539-42.
Indones J
150 Hasan et al Obstet Gynecol
